Clover Health Investments, Corp. CLOV
4.49
(0.02)
(0.44%)
as of 25 Sep
- Market cap
- $2.5B
- P/E
- 0.0×
Follow CLOV
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(17.08%) | (26.33%) | (16.86%) | (5.10%) | |
| (9.62%) | (15.25%) | (8.89%) | (2.84%) | ||
ROIC |
(26.10%) | (28.37%) | (26.18%) | (8.62%) | |
Return on Tangible Assets |
(40.80%) | (81.15%) | (48.12%) | (10.84%) | |
Average Days of Receivables |
11.92 | 17.99 | 12.13 | 10.78 | |
Free Cash Flow per Share |
(0.17) | (0.13) | 0.10 | 0.14 | |
Free Cash Flow |
(86.38) | (68.98) | 54.54 | 74.21 | |
Capital Expenditures |
(1.76) | (2.04) | (2.71) | (2.82) | |
Piotroski F-Score |
3.00 | 2.00 | 3.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
(15.56%) | (15.60%) | 10.54% | 12.44% | |
Accounts Receivable Turnover |
32.18 | 26.29 | 34.82 | 41.27 | |
Accounts Payable Turnover |
47.64 | 44.32 | 51.77 | 58.16 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
8.60 | 8.43 | 7.92 | 6.41 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
24.34% | 22.85% | 20.88% | 19.23% | |
Share Based Compensation of Revenue |
6.11% | 5.39% | 4.05% | 2.92% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.45 | 0.78 | (1.01) | (4.20) | |
Depreciation/Fixed assets |
(0.02) | (0.02) | (0.02) | 0.02 | |
Capex/Depreciation |
15.18 | 13.01 | 24.21 | (20.32) | |
Revenue per Share |
3.46 | 3.76 | 4.23 | 4.72 | |
Operating CF per Share |
(0.16) | (0.13) | 0.11 | 0.15 | |
Capex per Share |
0.00 | 0.00 | (0.01) | (0.01) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(3.29%) | (4.45%) | (2.58%) | (0.74%) |
Columns are period end dates